Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04056247 · ClinicalTrials.gov registry record
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments
A clinical trial of Stage IV Non-small Cell Lung Cancer and Stage IV Small Cell Lung Cancer, sponsored by OncoHost.
- Active
- Registry status
- 10,000
- Enrollment target
- 20
- Study locations
NCT04056247 is a study of Stage IV Non-small Cell Lung Cancer and Stage IV Small Cell Lung Cancer that is active but no longer recruiting, run by OncoHost. The registered enrollment target is 10,000 participants, above the 255-participant average among 23 other Stage IV Non-small Cell Lung Cancer trials with a reported enrollment target (3822% higher). The trial reports 20 study locations across 9 states.
The verdict
NCT04056247, a study of Stage IV Non-small Cell Lung Cancer and Stage IV Small Cell Lung Cancer, is active but no longer recruiting, sponsored by OncoHost.
- ACTIVE NOT RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The PROPHETIC study is a prospective, multi-center, international clinical study aimed at developing an algorithm to predict patient outcomes. The study involves analyzing the proteomic profiles of patients undergoing therapy to assess the likelihood of clinical benefit from their prescribed treatment. Blood samples are collected prior to and during the treatment period and analyzed as part of the ongoing development of thealgorithm.
Conditions Studied
Interventions
- OTHER Plasma sample collection
Study Locations (20)
Other
- Asklepois - Gauting
- Thoraxklinik Heidelberg gGmbH - Heidelberg
- Haemek Medical Center - Afula
- Barzilai Medical Center - Ashkelon
- Soroka Medical Center - Beersheba
- Shamir Medical Center - Be’er Ya‘aqov
- Bnai Zion Medical Center - Haifa
- Rambam Medical Center - Haifa
Florida
- Mayo Clinic - Jacksonville
- University of Miami - Miami
- Florida Cancer Specialist and Research Institute - Orlando
- Protean Biodiagnosics - Orlando
Texas
- Michael E. Debakey VA Medical Center - Houston
- 151-Christus Health St. Michael - Texarkana
Alabama
- Birmingham VAHCS - Birmingham
Illinois
- Northwest Community Healthcare - Rolling Meadows
Iowa
- Helen Nassif Community Cancer Center - Cedar Rapids
New Jersey
- Rutgers Cancer Institute - New Brunswick
New York
- Roswell Park - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2029-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04056247
The ClinicalTrials.gov registry entry for NCT04056247 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 255-participant average among 23 other Stage IV Non-small Cell Lung Cancer trials with a reported enrollment target (3822% higher). The listed sponsor is OncoHost, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Stage IV Non-small Cell Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Plasma sample collection is the first listed.
NCT04056247 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Other, Florida, Texas.
Frequently Asked Questions
What is clinical trial NCT04056247 about?
NCT04056247 is a clinical study titled "Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments". The PROPHETIC study is a prospective, multi-center, international clinical study aimed at developing an algorithm to predict patient outcomes. The study involves analyzing the proteomic profiles of patients undergoing therapy to assess the likelihood of clinical benefit from their prescribed treatme...
What is the current status of trial NCT04056247?
This trial is currently active not recruiting. The enrollment target is 10,000 participants. The study started on 2019-10-01. Estimated completion is 2029-10-01.
What conditions does trial NCT04056247 study?
This clinical trial studies the following conditions: Stage IV Non-small Cell Lung Cancer, Stage IV Small Cell Lung Cancer, Stage IV Malignant Melanoma, Stage III Unresectable Non-Small Cell Lung Cancer, Stage IIIb-d Malignant Melanoma.
What interventions are being tested in trial NCT04056247?
The interventions under investigation include: Plasma sample collection (OTHER).
Who is sponsoring clinical trial NCT04056247?
This trial is sponsored by OncoHost, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04056247 being conducted?
This trial has 20 study locations across Alabama, Florida, Illinois, Iowa, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage IV Non-small Cell Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
RECRUITING · Phase 1
-
Patient-centered, Optimal Integration of Survivorship and Palliative Care
RECRUITING · NA
-
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
RECRUITING · NA
-
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer
RECRUITING · NA
-
Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC
ACTIVE NOT RECRUITING · Phase 1
-
Ruxolitinib for Cancer Cachexia
ACTIVE NOT RECRUITING · Early Phase 1
Explore more on PlainTrial
Stage IV Non-small Cell Lung Cancer
All registered trials for this condition
Stage IV Small Cell Lung Cancer
All registered trials for this condition
Alabama
All trials with a study site in Alabama
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.